Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/29/2025

Corticosteroid Tapering Regimens

Introduction to Tapering

  • The American College of Physicians recommends tapering high-dose corticosteroids by 10 mg every 2 weeks until reaching 30 mg/day, then reducing by 5 mg every 2 weeks until 20 mg/day, followed by 2.5 mg reductions every 2 weeks until 10 mg/day, and finally decreasing by 1 mg every 4 weeks until discontinuation, for patients on high-dose corticosteroids (≥30 mg/day prednisone equivalent) 1, 2

Initial High-Dose Phase

  • Reduce by 10 mg every 2 weeks until the dose reaches 30 mg/day, as recommended by the Mayo Clinic 1, 2
  • Monitor for disease flare during this phase; if symptoms recur, immediately return to the pre-relapse dose and maintain for 4-8 weeks before attempting slower taper, according to Praxis Medical Insights 2

Intermediate Phase

  • Reduce by 5 mg every 2 weeks until reaching 20 mg/day, as recommended by the Mayo Clinic 1, 2
  • At this dose range, approaching the threshold for HPA axis suppression (20 mg/day for >3-4 weeks) is a concern, as noted by Praxis Medical Insights 3

Low-Dose Phase

  • Reduce by 2.5 mg every 2 weeks until reaching 10 mg/day, as recommended by the Mayo Clinic 1, 2
  • This slower taper allows gradual HPA axis recovery while maintaining disease control, according to Praxis Medical Insights 3

Physiologic Dose Phase

  • Reduce by 1 mg every 4 weeks until discontinuation, as recommended by the Mayo Clinic 1, 2
  • At doses below 10 mg/day, the risk of adrenal insufficiency becomes significant, as noted by Praxis Medical Insights 3

Critical Timing Considerations

  • HPA axis suppression should be anticipated in any patient receiving >7.5 mg daily for >3 weeks, according to Praxis Medical Insights 2
  • For courses lasting 3-10 days, no taper is necessary, as recommended by Praxis Medical Insights 3

Managing Disease Flare During Tapering

  • If symptoms recur, immediately return to the pre-relapse dose and maintain for 4-8 weeks before attempting a slower taper, according to Praxis Medical Insights 2
  • Consider adding steroid-sparing agents (azathioprine, mycophenolate mofetil, or methotrexate) if multiple relapses occur, as recommended by the Mayo Clinic and Praxis Medical Insights 1, 2

Stress Dosing Requirements

  • During acute illness or physiologic stress, double the current prednisone dose for 3 days for minor illness, as recommended by Praxis Medical Insights 2
  • All patients should carry a medical alert card/bracelet for adrenal insufficiency, according to Praxis Medical Insights 2

Accelerated Tapering With Steroid-Sparing Agents

  • Reduce by 5 mg every week until reaching 10 mg/day, which is more aggressive than standard tapering, if azathioprine or another steroid-sparing agent has been established for 2-3 months, as recommended by Praxis Medical Insights 2

Special Considerations for Specific Diseases

  • For immune-related adverse events, start at 1-2 mg/kg/day, taper over 4-6 weeks once symptoms improve to grade 1, as recommended by the Journal for ImmunoTherapy of Cancer and Praxis Medical Insights 4, 2
  • For inflammatory myopathies, the regimen outlined above (10 mg decrements, then 5 mg, then 2.5 mg, then 1 mg) is specifically validated, according to the Mayo Clinic 1
  • For pemphigus vulgaris, initial therapy at 1-2 mg/kg/day is standard, with similar tapering principles applied, as recommended by the British Journal of Dermatology 5